Replies to post #2992 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[king oil]

I agree that the science looks very good. The share structure is very disappointing. We knew that the reverse split would be followed by dilution but I doubt that most investors expected it to be as quick, extensive, and at such a low share price.

I don’t understand why they couldn’t wait until after the positive trial news to negotiate financing. They sold shares and warrants at a 50% discount. That is extreme in my opinion. Until those shares and warrants are absorbed it will be very difficult for the share price to recover to the level it was at a couple weeks ago.

I suppose the counter argument is that financing is scarce given COVID-19 situation. But the trial results could have overcome hesitancy to provide financing, again in my opinion.

If they burn thru this latest round of funding without generating more revenue the picture will be bleak for current shareholders. Hopefully the trials move ahead as expected and we are rewarded for sticking around.

I appreciate all the great info provided here by posters. It’s one of the better message boards because of you and the other contributors here.

[Trickshot]

Also the milestone payments from Chiesi, unless you considered that part of the royalty stream.